中低温停循环联合顺行脑灌注在全主动脉弓置换术中的安全性
基于ARCH国际主动脉数据库3,265例全主动脉弓置换术患者,比较中低温(20-28°C)与深低温(12-20°C)停循环联合顺行脑灌注的安全性。倾向性匹配669对后,中低温组体外循环时间和主动脉阻断时间更短,但脑灌注时间稍长;两组神经预后和院内死亡率无差异。中低温联合顺行脑灌注可安全用于全主动脉弓置换术。
要点
- 中低温联合顺行脑灌注可安全用于全主动脉弓置换术。
- 中低温组体外循环时间和主动脉阻断时间显著短于深低温组。
- 两组的神经预后和院内死亡率无显著差异。
核心结论
- 全主动脉弓置换术中采用中低温停循环联合顺行脑灌注可安全实施,手术风险可接受。
- 中低温联合顺行脑灌注是有效策略,可能免除深低温停循环的必要。
研究设计与样本
- 回顾性队列研究,查询ARCH国际主动脉数据库,纳入3,265例使用顺行脑灌注的全主动脉弓置换术患者。
- 按最低降温温度分为中低温组(20-28°C)和深低温组(12-20°C),采用15个变量进行倾向性匹配,得到669对匹配患者。
- 进行多因素分析。
主要发现
- 未匹配队列中,中低温组2,586例(79.2%),较深低温组更年轻(p < 0.001)且急诊手术更频繁(p < 0.001)。
- 倾向性匹配后,中低温组体外循环时间200分钟 vs 深低温组243分钟(p < 0.001),主动脉阻断时间120分钟 vs 142分钟(p < 0.001),脑灌注时间63分钟 vs 58分钟(p < 0.001)。
- 两组神经预后和院内死亡率无差异。
- 死亡风险因素包括体外循环时间(OR 1.006;p < 0.001)、合并二尖瓣手术(OR 3.070;p = 0.003)、急诊手术(OR 2.924;p < 0.001)和射血分数差(OR 3.133;p = 0.011)。
- 卒中独立风险因素包括冠心病(OR 1.856;p < 0.001)、脑血管疾病(OR 2.172;p < 0.001)、急诊手术(OR 2.109;p < 0.001)和体外循环时间(OR 1.004;p < 0.001)。
临床怎么用
- 全主动脉弓置换术可考虑采用中低温停循环联合顺行脑灌注替代深低温停循环。
- 关注体外循环时间、急诊手术、合并二尖瓣手术及射血分数差等死亡风险因素。
- 对合并冠心病或脑血管疾病患者,注意卒中风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Total aortic arch replacement (TOTAL) is a complicated operation and has traditionally required deep hypothermic circulatory arrest. In this study, the impact of moderate hypothermic circulatory arrest (MHCA) and antegrade cerebral perfusion (ACP) for TOTAL were examined. METHODS: The ARCH International aortic database was queried and 3,265 patients undergoing TOTAL using ACP were identified. Patients were divided into groups based on lowest cooling temperature: MHCA (20° to 28°C) or deep hypothermia (DHCA) (12° to 20°C). Propensity-matched scoring using 15 variables was used in 669 matched pairs. Multivariable analyses were performed. RESULTS: In the unmatched cohort, more patients underwent MHCA (2,586; 79.2%) who were also younger (p < 0.001) and more frequently underwent emergent operations (p < 0.001) than DHCA patients. For the propensity-matched patients, there were significant differences in cardiopulmonary bypass (CPB) time (MHCA 200 minutes versus DHCA 243 minutes, p < 0.001), aortic crossclamp time (MHCA 120 minutes versus DHCA 142 minutes, p < 0.001), and cerebral perfusion time (MHCA 63 minutes versus DHCA 58 minutes, p < 0.001). Of note, there was no difference in neurologic outcomes nor in-hospital mortality for the two temperature groups. Multivariable analysis of risk factors for mortality included CPB time (odds ratio [OR] 1.006; p < 0.001), concomitant mitral valve surgery (OR 3.070; p = 0.003), emergent operation (OR 2.924; p < 0.001), and poor ejection fraction (OR 3.133; p = 0.011). Independent risk factors for stroke included coronary artery disease (OR 1.856; p < 0.001), cerebral vascular disease (OR 2.172; p < 0.001), emergent operation (OR 2.109; p < 0.001), and CPB time (OR 1.004; p < 0.001). CONCLUSIONS: In this series, TOTAL with MHCA and ACP can be safely performed with acceptable operative risk. MHCA and ACP represent an effective strategy for TOTAL and may obviate the need for DHCA.
引用
- Keeling WB, Tian DH, Leshnower BG, et al. Safety of Moderate Hypothermia With Antegrade Cerebral Perfusion in Total Aortic Arch Replacement. Ann Thorac Surg. 2017. PMID: 29167026. doi:10.1016/j.athoracsur.2017.06.072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。